Search tips
Search criteria 


Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2010; 5(12): e15073.
Published online 2010 December 20. doi:  10.1371/journal.pone.0015073
PMCID: PMC3004791

The Effect of DNA-Dependent Protein Kinase on Adeno-Associated Virus Replication

Immo A. Hansen, Editor



DNA-dependent protein kinase (DNA-PK) is a DNA repair enzyme and plays an important role in determining the molecular fate of the rAAV genome. However, the effect this cellular enzyme on rAAV DNA replication remains elusive.

Methodology/Principal Findings

In the present study, we characterized the roles of DNA-PK on recombinant adeno-associated virus DNA replication. Inhibition of DNA-PK by a DNA-PK inhibitor or siRNA targeting DNA-PKcs significantly decreased replication of AAV in MO59K and 293 cells. Southern blot analysis showed that replicated rAAV DNA formed head-to-head or tail-to-tail junctions. The head-to-tail junction was low or undetectable suggesting AAV-ITR self-priming is the major mechanism for rAAV DNA replication. In an in vitro replication assay, anti-Ku80 antibody strongly inhibited rAAV replication, while anti-Ku70 antibody moderately decreased rAAV replication. Similarly, when Ku heterodimer (Ku70/80) was depleted, less replicated rAAV DNA were detected. Finally, we showed that AAV-ITRs directly interacted with Ku proteins.


Collectively, our results showed that that DNA-PK enhances rAAV replication through the interaction of Ku proteins and AAV-ITRs.


DNA-PK is a nuclear serine/threonine protein kinase that consists of a 460 kDa catalytic subunit (DNA-PKcs) and a heterodimer (Ku70 and Ku80). DNA-PK plays important roles in DNA repair and V(D)J recombination through nonhomologous end joining (NHEJ). When DNA-PK encounters DNA lesions such as DNA double strand break (DSB) damage by ionizing radiation, Ku70/80 binds with high affinity to DNA ends independent of their end sequence or structure [1], [2], [3]. The Ku heterodimer recruits DNA-PKcs to form an active DNA-PK holoenzyme. LigaseIV/XRCC4 interacts with DNA-PK on DNA ends, which leads to NHEJ [4], [5]. Several proteins including Mre11/Rad50/Nbs1 and Artemis are involved in this process [6], [7]. Activity of DNA-PKcs may be regulated by autophosphorylation of DNA-PKcs at seven putative phosphorylation sites including Thr2609 and Ser2056 [8], [9]. Cells or animals lacking DNA-PK functions are deficient in a protective response to ionizing radiation and various radiomimetic agents [10], [11]. DNA-PK is a potential target protein in many cancer therapeutics since inhibitors of DNA-PK can selectively sensitize tumor cells to ionizing radiation. Wortmannin, an inhibitor of PI 3-kinase, inhibits DNA-dependent protein kinase and sensitizes cells to ionizing radiation (IR) [12], [13]. In addition, wortmannin directly binds to the kinase domain of DNA-PKcs and inhibits the function of DNA-PKcs noncompetitively [14]. DNA-PK is a sensor molecule that determines the cellular fates by regulating cellular proteins related with cell cycles, DNA repair, and apoptosis [9], [15], [16], [17]. Paradoxically, the Ku70/80 complex can also inhibit nonhomologous end joining when it binds to the telomere complex, shelterin [18].

Adeno-associated virus (AAV) is a nonpathogenic human parvovirus that contains a linear single-stranded DNA (ssDNA) genome [19]. The AAV genome encodes two large open reading frames, rep and cap, that are flanked by 145 nucleotide inverted terminal repeats (ITRs). AAV has an interesting biphasic life cycle, either productive infection in the presence of a helper virus, e.g., adenovirus or herpes simplex virus (HSV), or latent infection in the absence of a helper virus. The ITRs comprise the Rep binding elements (RBE and RBE') and the terminal resolution site (trs) and form a T-shaped hairpin structure that serves as the primer for minimal origin of AAV DNA replication and for the site specific nicking of the AAV ITR at the trs that is required for repairing covalently closed ITRs during AAV replication [20], [21], [22], [23]. The large Rep proteins (Rep68 or Rep78) mediate viral DNA replication and trs nicking [20], [24], [25], [26], [27] and regulate AAV gene expression [28], [29], [30], [31], [32], [33], [34] and packaging [35], [36]. Rep68 or Rep78 also play important roles for site-specific integration of wild type AAV2 into human chromosome 19q13.3qter, named the AAVS1 locus [37], [38], [39]. AAV DNA replication requires the ITR, cellular polymerases, and helper virus-derived factors. The p5 promoter region that regulates rep gene expression is also involved in a reduced Rep-dependent replication and site-specific integration that occurs in the absence of the ITR and relies on the RBE and cryptic trs in the p5 promoter [40].

In addition to the Rep proteins and ITRs, AAV DNA replication requires cellular proteins and helper virus-derived factors depending on the helper virus used. In the presence of Ad, in vitro replication assays suggest that four cellular complexes are essential for AAV DNA replication; these are polymerase δ, proliferating cell nucelar antigen (PCNA), replication factor C (RFC), and minichromosome maintenance complex (MCM) [25], [41], [42], [43]. The Ad and cellular single stranded DNA binding proteins (DBP and RPA) have also been shown to stimulate AAV DNA replication in vitro [43], [44] [41]. Rep has been shown to interact with all of these cellular and viral proteins [44], [45].

In contrast to Ad helper infections, relatively little is known about cellular proteins involved in AAV replication during coinfection with Herpes simplex virus (HSV). The herpes helicase primase complex and single stranded DNA binding protein are essential for promoting AAV DNA replication in vivo at a minimal level [44], [46], [47]. However, expression of the HSV DBP and helicase/primase provide only 10% of the normal DNA replication seen with wild type herpes coinfection [47]. This suggests that other herpes genes provide essential functions and some of these have recently been identified, (ICP0, ICP4, ICP22) [48]. The herpes DNA polymerase, which appears to provide partial helper function under some conditions [46], [48], has also been shown to be completely dispensable for rAAV production [49], suggesting that a cellular polymerase may be necessary in the presence of Herpes coinfection.

We have previously reported that DNA-PK is involved in determining the molecular fate of the rAAV genome in skeletal muscle and in liver [50], [51]. However, the effect of DNA-PK on AAV replication remains elusive. Nash et al (44) have recently shown that Ku70/80 complex, which forms a complex with DNA-PK, as well as DNA-PK, both form a complex with Rep78 during productive infections in the presence of adenovirus. They also showed that the DNA-PK/Ku70/Ku80 complex stimulates AAV DNA replication in vitro, although it does not appear to be essential. In this report we examine the effect of DNA-PK/Ku70/80 on AAV DNA replication in the presence of HSV and Ad. In order to test the effect of DNA-PK on rAAV replication, we have employed both in vivo and in vitro replication assays. We demonstrated that inhibition of DNA-PK by wortmannin or siRNA resulted in decrease of rAAV replication in MO59K and 293 cells in the presence of Herpes virus and in 293 cells in the presence of Ad helper functions. We also confirmed that depletion of Ku proteins lead to a reduction of AAV replication in an in vitro assay using Ad infected extracts.


DNA-PK inhibitor, wortmannin Inhibits rAAV replication

In order to test the effect of DNA-PK on rAAV replication, we first employed wortmannin, an inhibitor of DNA-PK [14]. DNA-PK positive (+/+) cell lines, MO59K and 293 cells were infected with rAAV2-UF5 with or without recombinant herpes helper virus (containing the AAV2 rep and cap genes) [52]. Cells were treated with different concentrations of wortmannin and two days after viral co-infection, episomal DNA (Hirt DNA) was isolated. Replicated forms of rAAV-UF5 DNA including double-stranded monomer (about 3.4 kb), double-stranded dimer (about 6.8 kb) and high molecular weight concatamers (over 13 kb) were analyzed by Southern blot analysis using 32P labeled vector specific (CMV) probe. As shown in Figure 1, treatment of wortmannin decreased the rAAV genome replication in dose-dependent manner in both cell lines. No significant cytotoxicity was observed when wortmannin concentration was below 20 µM in MO59K cells, or below 5 µM in 293 cells. We noticed that the conversion of single-stranded AAV genome to double-stranded monomer or concatamers was more efficient in 293 cells than in MO59K cells, probably due to E1 gene expression in 293 cells [53], [54], [55].

Figure 1
rAAV replication in MO59K cells and 293 cell treated with wortmannin.

Targeting DNA-PKcs mRNA inhibits rAAV replication

The results above indicated that DNA-PK may play a role in enhancing rAAV replication. However, wortmannin inhibits not only DNA-PK, but also other protein kinases, such as phosphatidylinositol 3-kinase (PI-3). In order to pinpoint the role of DNA-PK, we employed synthetic siRNA to target DNA-PKcs mRNA. Synthetic siRNA at 100 pmole significantly decreased mRNA (Figure 2A) and protein levels (Figure 2B) in 293 cells, while control siRNA or Lipofectamine™ 2000 reagent alone showed no effect. These results demonstrated that siRNA was efficient for inhibition of DNA-PKcs. As shown in Figure 3A and B, inhibition of DNA-PKcs by siRNA resulted in a significant decrease of rAAV replication as compared with control siRNA treatment. The inhibitory effect of the siRNA on rAAV replication was dose dependent (Figure 3C). Since the rAAV genome is linear and single stranded DNA, the viral infection may affect DNA-PK activity [56], [57], [58]. To avoid the unwanted effect from viral transduction of rAAV and rHSV [59], we evaluated rAAV replication using transfected double stranded vector and helper plasmids. Twenty-four hours after siRNA transfection, 293 cells were co-transfected with pDG, which supplies all of the Ad helper genes, and pUF5. Two days after the transfection, Hirt DNA was isolated and digested with DpnI to remove plasmid DNA. Results from this study again showed that inhibition of DNA-PK decreased rAAV replication (Figure 3D).

Figure 2
Targeting DNA-PKcs by siRNA.
Figure 3
Targeting DNA-PKcs reduced rAAV replication.

Molecular analysis of replicated rAAV DNA

We and others have previously shown that in latent infections, rAAV DNA forms mainly head-to-tail (H-T) junctions and persists as an episome in liver and muscle cells. Cellular enzymes, such as DNA-PK play important roles in the junction formation and persistence of AAV DNA [50], [51] and would be expected to produce circular rAAV genomes with head to tail junctions. Although AAV is known to replicate by a hairpin priming mechanism, a rolling circle mechanism has been proposed during the establishment of latent infections [60], [61]. Unlike the self-priming model, which generates head-to-head (H-H) or tail-to-tail (T-T) junctions, the rolling circle model generates head-to-tail (H-T) junctions. In order to evaluate the structures of replicated rAAV junction and the effect of DNA-PK on junction formation, we digested Hirt DNA with unique restriction enzymes, XbaI (1-cutter), SacI (2-cutter), and NotI (2-cutter) as shown in Figure 4A. All of the possible fragments generated from these digests are listed in Figure 4B. Southern blot analysis using two different probes showed that all predicted fragments (H-H, T-T, free ends) were detected, except H-T junctions (Figure 4C). The low or undetectable levels of head to tail junctions suggested AAV-ITR self-priming was still the primary mechanism for AAV DNA replication. Inhibition of DNA-PK did not affect the type of AAV junction formed during AAV replication.

Figure 4
Structure analysis of replicated DNA.

In vitro AAV replication

In order to confirm the observation that inhibition of DNA-PK decreased rAAV replication in cells, we employed a previously developed in vitro replication assay to explore the role of DNA-PK and Ku70/80 [25], [43]. In this assay, the reaction contains purified Rep 68, dsAAV DNA template with covalently closed ends and nuclear extract (NE) from adenovirus-infected HeLa cells. Since HeLa cells express high levels of DNA-PK, we tested the effect of selective inhibition of each subunit of the DNA-PK complex by adding anti-DNA-PKcs, anti-Ku70, or anti-Ku80 antibodies to the HeLa NE before starting the AAV replication reaction. As shown in Figure 5A, addition of anti-Ku80 antibody significantly inhibited rAAV replication (70%, P<0.05), while anti-Ku70 antibody showed a moderate decrease of rAAV replication (33%, P = 0.074). However, we did not observe inhibition of AAV replication using anti-DNA-PKcs antibodies (Ab-23198–4127 or Ab-4cocktail). In order to rule out a non-specific effect of the antibodies on AAV replication, we performed the assay with HeLa nuclear extracts that had been depleted for DNA-PKcs or Ku heterodimer. Specific depletion of DNA-PKcs by anti-DNA-PKcs Ab-4Cocktail and Ku proteins by anti-Ku70/80 (Ku-Ab3) was observed by Western blotting (Figure 5C). As shown in Figure 5D and 5E, depletion of Ku70/80 decreased AAV replication (P<0.05 by one-tailed distribution), while depletion of DNA-PK-cs did not. The results from these in vitro replication studies confirmed the previous report that Ku70/80 interacts with AAV Rep protein in vivo, and that they can enhance in vitro AAV DNA replication and partially substitute for MCM complex [45].

Figure 5
In vitro AAV replication.

AAV-ITRs interact with Ku proteins

In order to test for a direct interaction between the AAV ITR and DNA-PK, we built an AAV-ITR by annealing and ligating three synthetic oligonuceotides. This ITR was then linked to a magnetic particle (Figure 6A), and as expected, the ITR interacted with Rep 78 (Figure 6B, right panel). In addition, using the ITR coated magnetic particles, we successfully pulled down and isolated Ku70 and Ku80 proteins (Figure 6B, left panel). To eliminate the possibility that incomplete ITRs or single stranded DNA interacted with the Ku proteins, we treated the ITR coated beads with exonuclease III to remove any partially assembled ITRs. As shown in Figure 6C, exonuclease III treatment did not affect the interaction between the AAV-ITR and Ku proteins. The interaction was also found to be a function of the concentration of Ku proteins. Finally, when free competitor AAV-ITR was added to the reaction, less Ku protein was pulled down (Figure 6D right) although the streptavidin-coated beads alone weekly interact with Ku 70 (Figure 6D left). These results demonstrated that Ku proteins can directly bind to hairpined AAV-ITRs, even in the absence of Rep protein.

Figure 6
AAT-ITR interacts with Ku proteins.


AAV replication has been intensively investigated and the contributions of AAV ITR sequences and Rep proteins have been reasonably well defined [20], [21], [22], [23], [25], [62], [63], [64], [65], [66], [67], [68]. However, the effects of cellular proteins on AAV replication are not completely understood. Although the minimum set of proteins required to replicate AAV DNA efficiently in vitro has been identified for both Herpes and Ad infected cells [41], [42], [43], [44], [46], [47], [49], [69], [70], [71], it has recently been reported that Rep protein interacts with 188 cellular proteins [45]. Some of these Rep-interacting cellular factors play important roles in cellular DNA replication or repair and are likely to have a role in AAV DNA replication as well. Understanding these mechanism(s) will enable us to enhance rAAV vector production and to develop a safe gene delivery system. In the present study, we focused on the role of the DNA-PK complex (DNA-PKcs and Ku70/80) in AAV DNA replication.

Our results showed that reduction of DNA-PK at the protein or RNA levels decreased rAAV replication, suggesting that one or more components of the DNA-PK complex can enhance AAV replication. In vivo, long-term inhibition of DNA-PKcs by wortmannin and siRNA reduced rAAV replication in both MO59K and 293 cells (Figs. 1, ,22 and and3),3), indicating that DNA-PKcs plays an important role in rAAV replication. Furthermore, DNA-PKcs siRNA reduced AAV DNA replication when either Herpes virus or Ad helper functions were used (Fig. 3). However, when cell-free extracts were used in an in vitro replication assay, depletion of DNA-PKcs did not affect rAAV replication suggesting that the effect of DNA-PKcs observed in vivo was indirectly through acting on downstream factors, such as Ku proteins. Indeed, our results showed that Ku70 and Ku80, had a clear effect in vitro when they were depleted by either antibody precipitation or antibody addition (Fig. 5). Finally, we showed that the components of the DNA-PK complex, particularly Ku70/80, could bind to a hairpinned AAV ITR. Because the magnetically tagged substrate used in these binding studies had a DNA end that was blocked with a magnetic bead, our results showed the direct interaction between Ku proteins and close-ended AAT-ITR. These results are consistent with observations reported previously using a ChIP assay [72]. Our results also are consistent with the recent report by Nash et al [45], who showed that purified Ku70/80 could partially substitute for the MCM helicase complex in an AAV DNA replication assay. This group also showed by antibody co-precipitation that Ku70/80 formed a complex with Rep78 and 68 in vivo that was independent of the presence of DNA. Together, these results suggest that the enhancing effect of DNA-PKcs that we observed in vivo was probably through phosphorylation of Ku proteins, and suggested that Ku protein activated by DNA-Pkcs stimulated AAV replication in vitro in the absence of DNA-PKcs.

DNA-PK is a DNA repair enzyme consisting of a large catalytic subunit (DNA-PKcs), which has ser/thr kinase, and a heterodimeric complex consisting of Ku70 and Ku80 [73]. The Ku heterodimer associates tightly with double stranded DNA breaks and recruits DNA-PKcs, XRCC4 and Ligase IV to repair the DNA break by non-homologous end joining [74], [75], [76]. Ku also binds to telomeres via a high affinity interaction with TRF1, a component of the telomere shelterin complex and has a role in maintaining the stability of telomeres [18]. In contrast to its role in DNA repair, when Ku binds telomeres, it prevents telomere end joining. Finally, Ku has also been shown to have a 3′ to 5′ helicase activity and ATPase activity [77] and these activities appear to be unrelated to its binding of DNA ends.

We and others have shown that DNA-PK plays an important role in processing recombinant AAV genomes [51], [72], [78], [79], [80], [81]. Injection of rAAV into scid mice (DNA-PKcs negative) showed a persistence of linear episomal rAAV DNA containing free ends in mouse tissue, in contrast to normal mice, in which all of the free ends had been joined predominantly in a head to tail fashion [78], [79]. This result was consistent with the primary role of the DNA-PK complex in NHEJ, and suggested that this mechanism promoted rAAV DNA circulization, a key step in establishing stable transduction. Curiously, Zentilin et al [72] showed that in short term cell culture experiments (48 hrs), transduction was increased in Ku80 negative cell lines in the presence of hydroxyurea, suggesting that alternative mechanisms for forming transducing genomes can exist in the absence of DNA synthesis. In contrast, the results reported here showed that AAV DNA synthesis in the presence of helper virus functions did not result in circular intermediates or head to tail junctions, regardless of whether Ku70/86 was activated by DNA-PKcs (Fig 5). This suggests that the primary role of Ku70/80 in stimulating AAV DNA replication is unrelated to its role in promoting NHEJ or transduction. Our results are consistent with the recent report that AAV replication in the presence of Ad coinfection stimulated a DNA damage response that was primarily due to DNA-PKcs [58].

Given its inhibition of telomere end joining and its DNA helicase activity, we can suggest two general mechanisms by which Ku70/80 might stimulate AAV DNA synthesis. First, the interaction with Rep and the ITR may prevent NHEJ of AAV DNA replicative intermediates. This would be consistent with the finding that the protein complex containing the Ad E4 orf 6 and E1b 55K proteins targets the Mre11/Rad50/Nbs1 complex (MRN) for degradation [82]. In the absence of these two Ad helper functions for AAV (E1b55K and E4orf6), Ad DNA forms concatemers, thereby inhibiting Ad DNA replication. The MRN complex also localizes to AAV replication centers in the presence of Ad coinfection and inhibits AAV DNA replication in the absence of the E4orf6/E1b complex [83]. Therefore, the helper function provided by E1b and E4orf6 is believed in part to be the inhibition of MRN mediated NHEJ during AAV DNA replication. By binding to AAV ITRs, Ku70/80 may also prevent interaction of the ITR with MRN. Furthermore, by binding to the Rep-ITR complex, Ku itself may be prevented from recruiting the other components of the DNA-PK NHEJ pathway. Thus, binding of Ku to the ITR and Rep would inhibit the two major NHEJ pathways in mammalian cells.

Ku70/80 may also play a role in strand displacement synthesis. We have shown previously that AAV DNA replication can be reconstituted in vitro with purified proteins, including Rep, pol δ, PCNA and RFC [41], [42]. Here and elsewhere, we have also shown that replication can be at least partially reconstituted by substituting Ku for MCM [45]. Both proteins have similar 3′ DNA helicase activities that prefer a replication fork as a substrate [77], [84]; thus, both could function in AAV DNA replication as strand displacement helicases. Neither has activity on blunt ended DNA molecules [77], [84] and, therefore, the initial melting of AAV ends may be the function of Rep, which can bind to a Rep binding element within the ITR and unwind the end [85]. Once a nascent fork is established, either Ku or MCM can load onto the 3′ strand and unwind the rest of the ITR to form the hairpin primer required for loading DNA polymerase and executing strand displacement synthesis.

In summary, we have presented evidence both in vivo and in vitro that the DNA-PK complex and in particular Ku70/80 stimulates AAV DNA replication in the presence of both Ad and Herpes coinfection. We have also suggested two possible mechanisms that might account for this activity and guide future experiments.

Materials and Methods

Cells and Reagents

A human glioma cell line (MO59K) was obtained from ATCC and was cultured in DMEM/F-12 medium (Cellgrow).Human embryonic kidney 293 cells (Microbix) were cultured in Dulbecco's Minimal Essential Medium (DMEM). All media were supplemented with 10% fetal bovine serum (Cellgro), penicillin (100 U/ml) and streptomycin (100 µg/ml). Wortmannin (Sigma) was dissolved in DMSO at 10 mM and stored at −80°C.

rAAV transduction

The rAAV2-UF5 vector was produced at the University of Florida Gene Therapy Center as described previously [86]. This vector contains green fluorescent protein (GFP) cDNA driven by cytomegalovirus (CMV) promoter. The titer of the rAAV-UF5 used in this study was 2.5×1013 physical particles/ml (1×1012 infectious unit/ml). To test AAV replication from viral DNA, cells were infected with rAAV2-UF5 at 1000 particles/cell or co-infected without recombinant HSV helper vector which contains AAV rep and cap genes [52]. To test AAV replication from plasmid DNA, cells were transfected 1.2 µg of helper plasmid (pDG), and 0.8 µg of pTR-UF5 by using Lipofectamine 2000™ (Invitrogen). Hirt DNA was purified two days after viral infection and was used for Southern blot analysis to detect replicated forms of AAV genome. The densitometic quantification of AAV genomes was performed with Kodak Gel Image Software.

siRNA transfection

Two double stranded RNA molecules were purchased from Ambion (Austin, TX). The siRNA for DNA-PKcs (5′-GAU CGC ACC UUA CUC UGU U-3′) targets the sequences of 352 base and downstream sequences of human DNA-PKcs mRNA [87]. Silencer™ Negative Control #2 siRNA from Ambion which does not induce nonspecific effects on gene expression was used as a transfection control. 293 cells at the number of 2.5×105 cells/well were cultured in 6-well plates and transfected with 100 pmole of siRNA using Lipofectamine™ 2000 (Invitrogen). Next day, siRNA transfected cells were infected or transfected to test AAV replication as described above.


Total RNA was extracted from siRNA treated cells using Trizol™ reagent (Invitrogen) and RT-PCR was performed with Access™ RT-PCR kit (Promega) using 1 µg total RNA. Primers were derived from the coding region of DNA-PK cDNA (upstream primer: 5′-ACT GAC ACA GAC TGC AGA TGG AAG-3′, downstream primer: 5′-AGG GTG GAA AGA AAG AGA AGG TGG-3′). Beta-actin was used as a control (upstream primer: 5′-TCA CCA TGG ATG ATG ATA TCG CCG-3′, downstream primer: 5′-ACA TGA TCT GGG TCA TCT TCT CGC). Synthesis of the first strand cDNA was performed at 48°C for 45 min. The PCR were performed at 96°C for 1 min, 56°C for 1 min and 72°C for 2 min for 35 cycles. The amplified PCR products were fractionated on a 1% agarose gel.

Western blot analysis

For western blot analysis, cell pellets were lysed in M-PER™ mammalian protein extraction reagent (Pierce) supplemented with protease inhibitors (leupeptin, pepstatin, aprotinin, antipain, 1 µg/ml each) and PMSF (at 1 mM). The protein concentration was determined using BCA kit (Pierce). Thirty micrograms of total cellular proteins were separated on 8% SDS-polyacrylamide gel and transferred onto a nitrocellulose membrane (Amersham). The mouse anti-DNA-PKcs (DNA- PKcs Ab-41–4127) or mouse anti-Ku80 (Ku Ab-2610–705) or mouse anti-Ku70 (Ku Ab-4506–541) (all antibodies were purchased from NeoMarkers) was used to detect DNA-PKcs, or Ku80 or Ku70 respectively. Horseradish peroxidase-conjugated goat anti-mouse IgG was then used and the signal was detected using ECL (Amersham).

In vitro AAV replication assay

In order to inhibit DNA-PK subunits, 25 µg (1 µl) of Ad-infected HeLa cell nuclear extract was preincubated with 1 µl of specific antibodies against each subunits of DNA-PK (each 200 µg/ml) for 30 min at 37°C. The AAV DNA replication assay was performed as described previously [25]. Briefly, preincubated Ad-infected HeLa cell extract with antibodies was incubated in a reaction buffer containing 30 mM HEPES (pH 7.5), 7 mM MgCl2, 0.5 mM DTT, 100 µM each dNTP, 25 µCi of [a-32P] dATP, 4 mM ATP, 40 mM creatine phosphate, 1 µg of creatine phosphokinase, 0.1 µg of NE substrate DNA, and 1 to 80 U of Rep68 baculovirus extract for 4 h at 37°C. After incubation, the reaction mixture was treated with Proteinase K and extracted with phenol/chloroform. DNA was precipitated in ethanol. The DNA was digested with DpnI to remove bacterial DNA and was separated by 0.8% agarose gel. X-ray film was exposed on a dried gel.


In order to deplete DNA-PK subunits, 25 mg of Ad-infected HeLa cell extract was mixed with 30 µl of anti-DNA-PKcs (DNA- PKcs Ab-4cocktail), anti-Ku70/80 (Ku Ab-3) or control antibody (mouse IgG2a Ab-1, Neomarkers) and incubated at 4°C overnight. Each reaction was added with 50 µl of ProteinG-agarose (Calbiochem) and incubated at 4°C overnight. DNA-PK subunits interacted with the agarose beads were pelleted by centrifugation. Supernatants were harvested carefully. This procedure was repeated three times. The supernatant was used for in vitro AAV replication studies as described above after confirm the DNA-PK depletion by Western blot analysis.

Construction of synthetic AAV-ITR

A T-shaped AAV ITR was built by annealing and ligating three synthetic oligos, ITR 1 (65-mer): 5′-pGCTCGCTCACTGAGGCCGCCCGGGCAAAGCCCGGGCGTCGGGCGACCTTTGGTCGCCCGGCCTCA-3′, ITR 2 (35-mer): 5′-pGTGAGCGAGCGAGCGCGCAGAGAGGGAGTGGCCAA-3′, ITR 3 (19-mer): 5′-pTTGGCCACTCCCTCTCTGCGCGCTC-3′ (Figure 6A). This ITR was ligated with biotinated oligonucleotides, which can bind to streptavidin coated magnetic particles (Roche Inc).

Assay for interaction between DNA-PK and AAV ITR DNA

AAV ITR on magnetic bead was incubated with purified DNA-PK (containing DNA-PKcs, Ku80 and Ku70), HeLa nuclear extract or Rep78 at room temperature or 37°C. The incubation was performed in one of two buffers overnight containing either 25 mM HEPES (pH7.5), 5 mM MgCL2, 1 mM DTT and 1% BSA or 20 mM HEPES (pH7.6), 1 mM EDTA, 10mM NH4SO4, 1mM DTT, 0.2% Tween 20 and 30 mM KCL. After incubation, the magnetic beads were held by a magnet and washed 3 times with the binding buffer. AAV-ITR binding proteins were eluted out, dialyzed overnight following the instruction of the kit, and subjected to western blot analysis.


Competing Interests: N.M. is an inventor of patents held by the University of Florida related to recombinant AAV technology. He also owns equity in a gene therapy company (AGTC) that is commercializing AAV for gene therapy applications and serves on their Board of Directors. He receives no monetary compensation from AGTC or any other commercial entity. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Funding: This work was supported by National Institutes of Health grants (P01-DK58327, PO1 HL59412, PO1 HL51811) to S.S., N.M. and B.B., and grants from Juvenile Diabetes Research Foundation (JDRF) and Alpha One Foundation to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Blier PR, Griffith AJ, Craft J, Hardin JA. Binding of Ku protein to DNA. Measurement of affinity for ends and demonstration of binding to nicks. J Biol Chem. 1993;268:7594–7601. [PubMed]
2. Griffith AJ, Blier PR, Mimori T, Hardin JA. Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA. J Biol Chem. 1992;267:331–338. [PubMed]
3. Walker JR, Corpina RA, Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature. 2001;412:607–614. [PubMed]
4. Chen L, Trujillo K, Sung P, Tomkinson AE. Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase. J Biol Chem. 2000;275:26196–26205. [PubMed]
5. Drouet J, Delteil C, Lefrancois J, Concannon P, Salles B, et al. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. J Biol Chem. 2005;280:7060–7069. [PubMed]
6. Ma Y, Pannicke U, Schwarz K, Lieber MR. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell. 2002;108:781–794. [PubMed]
7. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2001;105:177–186. [PubMed]
8. Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 2002;16:2333–2338. [PubMed]
9. Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, et al. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem. 2005;280:14709–14715. [PubMed]
10. Shinohara ET, Geng L, Tan J, Chen H, Shir Y, et al. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res. 2005;65:4987–4992. [PubMed]
11. Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, et al. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res. 2005;65:4368–4375. [PubMed]
12. Boulton S, Kyle S, Yalcintepe L, Durkacz BW. Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. Carcinogenesis. 1996;17:2285–2290. [PubMed]
13. Price BD, Youmell MB. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res. 1996;56:246–250. [PubMed]
14. Izzard RA, Jackson SP, Smith GC. Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res. 1999;59:2581–2586. [PubMed]
15. Woo RA, Jack MT, Xu Y, Burma S, Chen DJ, et al. DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. Embo J. 2002;21:3000–3008. [PubMed]
16. Yamaguchi S, Hasegawa M, Aizawa S, Tanaka K, Yoshida K, et al. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70. Leuk Res. 2005;29:307–316. [PubMed]
17. Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, et al. Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol. 1998;18:6719–6728. [PMC free article] [PubMed]
18. Hsu HL, Gilley D, Galande SA, Hande MP, Allen B, et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 2000;14:2807–2812. [PubMed]
19. Berns KI. Parvoviridae: The Viruses and their replication. In: Fields B, editor. Fields Virology. Philadelphia, PA: Raven Press; 1996. pp. 2173–2197.
20. Im DS, Muzyczka N. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell. 1990;61:447–457. [PubMed]
21. Brister JR, Muzyczka N. Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification. J Virol. 1999;73:9325–9336. [PMC free article] [PubMed]
22. Brister JR, Muzyczka N. Mechanism of Rep-mediated adeno-associated virus origin nicking. J Virol. 2000;74:7762–7771. [PMC free article] [PubMed]
23. Weitzman MD, Kyostio SR, Kotin RM, Owens RA. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci U S A. 1994;91:5808–5812. [PubMed]
24. Hermonat PL, Labow MA, Wright R, Berns KI, Muzyczka N. Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol. 1984;51:329–339. [PMC free article] [PubMed]
25. Ni TH, Zhou X, McCarty DM, Zolotukhin I, Muzyczka N. In vitro replication of adeno-associated virus DNA. J Virol. 1994;68:1128–1138. [PMC free article] [PubMed]
26. Ward P, Urcelay E, Kotin R, Safer B, Berns KI. Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol. 1994;68:6029–6037. [PMC free article] [PubMed]
27. Ward P, Berns KI. In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J Virol. 1996;70:4495–4501. [PMC free article] [PubMed]
28. Beaton A, Palumbo P, Berns KI. Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol. 1989;63:4450–4454. [PMC free article] [PubMed]
29. Labow MA, Hermonat PL, Berns KI. Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol. 1986;60:251–258. [PMC free article] [PubMed]
30. Pereira DJ, McCarty DM, Muzyczka N. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol. 1997;71:1079–1088. [PMC free article] [PubMed]
31. Pereira DJ, Muzyczka N. The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation. J Virol. 1997;71:4300–4309. [PMC free article] [PubMed]
32. Pereira DJ, Muzyczka N. The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. J Virol. 1997;71:1747–1756. [PMC free article] [PubMed]
33. McCarty DM, Christensen M, Muzyczka N. Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J Virol. 1991;65:2936–2945. [PMC free article] [PubMed]
34. Weger S, Wistuba A, Grimm D, Kleinschmidt JA. Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J Virol. 1997;71:8437–8447. [PMC free article] [PubMed]
35. Dubielzig R, King JA, Weger S, Kern A, Kleinschmidt JA. Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes. J Virol. 1999;73:8989–8998. [PMC free article] [PubMed]
36. King JA, Dubielzig R, Grimm D, Kleinschmidt JA. DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J. 2001;20:3282–3291. [PubMed]
37. Kotin RM, Siniscalco M, Samulski RJ, Zhu XD, Hunter L, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A. 1990;87:2211–2215. [PubMed]
38. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. Embo J. 1991;10:3941–3950. [PubMed]
39. Balague C, Kalla M, Zhang WW. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol. 1997;71:3299–3306. [PMC free article] [PubMed]
40. Philpott NJ, Gomos J, Berns KI, Falck-Pedersen E. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc Natl Acad Sci U S A. 2002;99:12381–12385. [PubMed]
41. Nash K, Chen W, McDonald WF, Zhou X, Muzyczka N. Purification of host cell enzymes involved in adeno-associated virus DNA replication. J Virol. 2007;81:5777–5787. [PMC free article] [PubMed]
42. Nash K, Chen W, Muzyczka N. Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins. J Virol. 2008;82:1458–1464. [PMC free article] [PubMed]
43. Ni TH, McDonald WF, Zolotukhin I, Melendy T, Waga S, et al. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection. J Virol. 1998;72:2777–2787. [PMC free article] [PubMed]
44. Stracker TH, Cassell GD, Ward P, Loo YM, van Breukelen B, et al. The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication. J Virol. 2004;78:441–453. [PMC free article] [PubMed]
45. Nash K, Chen W, Salganik M, Muzyczka N. Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol. 2009;83:454–469. [PMC free article] [PubMed]
46. Weindler FW, Heilbronn R. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J Virol. 1991;65:2476–2483. [PMC free article] [PubMed]
47. Slanina H, Weger S, Stow ND, Kuhrs A, Heilbronn R. Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication. J Virol. 2006;80:5241–5250. [PMC free article] [PubMed]
48. Alazard-Dany N, Nicolas A, Ploquin A, Strasser R, Greco A, et al. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. PLoS Pathog. 2009;5:e1000340. [PMC free article] [PubMed]
49. Toublanc E, Benraiss A, Bonnin D, Blouin V, Brument N, et al. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines. J Gene Med. 2004;6:555–564. [PubMed]
50. Song S, Morgan M, Ellis T, Poirier A, Chesnut K, et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A. 1998;95:14384–14388. [PubMed]
51. Song S, Lu Y, Choi YK, Han Y, Tang Q, et al. DNA-dependent PK inhibits adeno-associated virus DNA integration. Proc Natl Acad Sci U S A. 2004;101:2112–2116. [PubMed]
52. Conway JE, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J Virol. 1997;71:8780–8789. [PMC free article] [PubMed]
53. Chang CT, Chen YL, Lee SH, Lue CM, Lin MT. The inhibition of prostaglandin E1-induced corneal neovascularization by steroid eye drops. Taiwan Yi Xue Hui Za Zhi. 1989;88:707–711. [PubMed]
54. Chang YN, Hsu HT, Hung MS, Chang CL, Li JG, et al. Effects of PGE1 on platelet deformability. Chin J Physiol. 1990;33:31–40. [PubMed]
55. Laughlin CA, Jones N, Carter BJ. Effect of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus. J Virol. 1982;41:868–876. [PMC free article] [PubMed]
56. Jurvansuu J, Fragkos M, Ingemarsdotter C, Beard P. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling. J Mol Biol. 2007;372:397–406. [PubMed]
57. Jurvansuu J, Raj K, Stasiak A, Beard P. Viral transport of DNA damage that mimics a stalled replication fork. J Virol. 2005;79:569–580. [PMC free article] [PubMed]
58. Schwartz RA, Carson CT, Schuberth C, Weitzman MD. Adeno-associated virus replication induces a DNA damage response coordinated by DNA-dependent protein kinase. J Virol. 2009;83:6269–6278. [PMC free article] [PubMed]
59. Parkinson J, Lees-Miller SP, Everett RD. Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol. 1999;73:650–657. [PMC free article] [PubMed]
60. Laughlin CA, Cardellichio CB, Coon HC. Latent infection of KB cells with adeno-associated virus type 2. J Virol. 1986;60:515–524. [PMC free article] [PubMed]
61. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol. 1988;62:1963–1973. [PMC free article] [PubMed]
62. Davis MD, Wu J, Owens RA. Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J Virol. 2000;74:2936–2942. [PMC free article] [PubMed]
63. Davis MD, Wonderling RS, Walker SL, Owens RA. Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro. J Virol. 1999;73:2084–2093. [PMC free article] [PubMed]
64. Wu J, Davis MD, Owens RA. Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins. J Virol. 1999;73:8235–8244. [PMC free article] [PubMed]
65. Walker SL, Wonderling RS, Owens RA. Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity. J Virol. 1997;71:2722–2730. [PMC free article] [PubMed]
66. Walker SL, Wonderling RS, Owens RA. Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J Virol. 1997;71:6996–7004. [PMC free article] [PubMed]
67. McCarty DM, Pereira DJ, Zolotukhin I, Zhou X, Ryan JH, et al. Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol. 1994;68:4988–4997. [PMC free article] [PubMed]
68. Ryan JH, Zolotukhin S, Muzyczka N. Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J Virol. 1996;70:1542–1553. [PMC free article] [PubMed]
69. Yalkinoglu AO, Heilbronn R, Burkle A, Schlehofer JR, zur Hausen H. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 1988;48:3123–3129. [PubMed]
70. Ward P, Dean FB, O'Donnell ME, Berns KI. Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication. J Virol. 1998;72:420–427. [PMC free article] [PubMed]
71. Ward P, Falkenberg M, Elias P, Weitzman M, Linden RM. Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system. J Virol. 2001;75:10250–10258. [PMC free article] [PubMed]
72. Zentilin L, Marcello A, Giacca M. Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J Virol. 2001;75:12279–12287. [PMC free article] [PubMed]
73. Gullo C, Au M, Feng G, Teoh G. The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta. 2006;1765:223–234. [PubMed]
74. Singleton BK, Torres-Arzayus MI, Rottinghaus ST, Taccioli GE, Jeggo PA. The C terminus of Ku80 activates the DNA-dependent protein kinase catalytic subunit. Mol Cell Biol. 1999;19:3267–3277. [PMC free article] [PubMed]
75. Ding Q, Reddy YV, Wang W, Woods T, Douglas P, et al. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol. 2003;23:5836–5848. [PMC free article] [PubMed]
76. Block WD, Yu Y, Merkle D, Gifford JL, Ding Q, et al. Autophosphorylation-dependent remodeling of the DNA-dependent protein kinase catalytic subunit regulates ligation of DNA ends. Nucleic Acids Res. 2004;32:4351–4357. [PMC free article] [PubMed]
77. Tuteja N, Tuteja R, Ochem A, Taneja P, Huang NW, et al. Human DNA helicase II: a novel DNA unwinding enzyme identified as the Ku autoantigen. EMBO J. 1994;13:4991–5001. [PubMed]
78. Duan D, Yue Y, Engelhardt JF. Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. J Virol. 2003;77:4751–4759. [PMC free article] [PubMed]
79. Song S, Laipis PJ, Berns KI, Flotte TR. Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc Natl Acad Sci U S A. 2001;98:4084–4088. [PubMed]
80. Choi VW, McCarty DM, Samulski RJ. Host cell DNA repair pathways in adeno-associated viral genome processing. J Virol. 2006;80:10346–10356. [PMC free article] [PubMed]
81. Inagaki K, Ma C, Storm TA, Kay MA, Nakai H. The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice. J Virol. 2007;81:11304–11321. [PMC free article] [PubMed]
82. Stracker TH, Carson CT, Weitzman MD. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 2002;418:348–352. [PubMed]
83. Schwartz RA, Palacios JA, Cassell GD, Adam S, Giacca M, et al. The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication. J Virol. 2007;81:12936–12945. [PMC free article] [PubMed]
84. Kaplan DL, Davey MJ, O'Donnell M. Mcm4,6,7 uses a “pump in ring” mechanism to unwind DNA by steric exclusion and actively translocate along a duplex. J Biol Chem. 2003;278:49171–49182. [PubMed]
85. Zhou X, Zolotukhin I, Im DS, Muzyczka N. Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities. J Virol. 1999;73:1580–1590. [PMC free article] [PubMed]
86. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N. A “humanized” green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol. 1996;70:4646–4654. [PMC free article] [PubMed]
87. Peng Y, Zhang Q, Nagasawa H, Okayasu R, Liber HL, et al. Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 2002;62:6400–6404. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science